120 related articles for article (PubMed ID: 34389918)
1. An integrative approach based on GC-qMS and NMR metabolomics data as a comprehensive strategy to search potential breast cancer biomarkers.
Silva CL; Perestrelo R; Capelinha F; Tomás H; Câmara JS
Metabolomics; 2021 Aug; 17(8):72. PubMed ID: 34389918
[TBL] [Abstract][Full Text] [Related]
2. Untargeted Urinary
Silva CL; Olival A; Perestrelo R; Silva P; Tomás H; Câmara JS
Metabolites; 2019 Nov; 9(11):. PubMed ID: 31703396
[TBL] [Abstract][Full Text] [Related]
3. Urinary Metabolomic Profiling in Chronic Hepatitis B Viral Infection Using Gas Chromatography/Mass Spectrometry.
Dittharot K; Jittorntam P; Wilairat P; Sobhonslidsuk A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):741-748. PubMed ID: 29582629
[TBL] [Abstract][Full Text] [Related]
4. NMR metabolomics study of follicular fluid in women with cancer resorting to fertility preservation.
Castiglione Morelli MA; Iuliano A; Schettini SCA; Petruzzi D; Ferri A; Colucci P; Viggiani L; Cuviello F; Ostuni A
J Assist Reprod Genet; 2018 Nov; 35(11):2063-2070. PubMed ID: 30069850
[TBL] [Abstract][Full Text] [Related]
5. Nuclear magnetic resonance and surface-assisted laser desorption/ionization mass spectrometry-based serum metabolomics of kidney cancer.
Nizioł J; Ossoliński K; Tripet BP; Copié V; Arendowski A; Ruman T
Anal Bioanal Chem; 2020 Sep; 412(23):5827-5841. PubMed ID: 32661677
[TBL] [Abstract][Full Text] [Related]
6. Metabolite signature of human malignant thyroid tissue: A systematic review and meta-analysis.
Razavi SA; Khorsand B; Salehipour P; Hedayati M
Cancer Med; 2024 Apr; 13(8):e7184. PubMed ID: 38646957
[TBL] [Abstract][Full Text] [Related]
7. Volatile metabolomic signature of human breast cancer cell lines.
Silva CL; Perestrelo R; Silva P; Tomás H; Câmara JS
Sci Rep; 2017 Mar; 7():43969. PubMed ID: 28256598
[TBL] [Abstract][Full Text] [Related]
8. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine.
Lima AR; Pinto J; Azevedo AI; Barros-Silva D; Jerónimo C; Henrique R; de Lourdes Bastos M; Guedes de Pinho P; Carvalho M
Br J Cancer; 2019 Nov; 121(10):857-868. PubMed ID: 31588123
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic characterization of nipple aspirate fluid by (1)H NMR spectroscopy and GC-MS.
Tredwell GD; Miller JA; Chow HH; Thompson PA; Keun HC
J Proteome Res; 2014 Feb; 13(2):883-9. PubMed ID: 24364541
[TBL] [Abstract][Full Text] [Related]
10. Identification of Metabolic Alterations in Breast Cancer Using Mass Spectrometry-Based Metabolomic Analysis.
Fan S; Shahid M; Jin P; Asher A; Kim J
Metabolites; 2020 Apr; 10(4):. PubMed ID: 32344578
[TBL] [Abstract][Full Text] [Related]
11. Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker.
Izquierdo-Garcia JL; Comella-Del-Barrio P; Campos-Olivas R; Villar-Hernández R; Prat-Aymerich C; De Souza-Galvão ML; Jiménez-Fuentes MA; Ruiz-Manzano J; Stojanovic Z; González A; Serra-Vidal M; García-García E; Muriel-Moreno B; Millet JP; Molina-Pinargote I; Casas X; Santiago J; Sabriá F; Martos C; Herzmann C; Ruiz-Cabello J; Domínguez J
Sci Rep; 2020 Dec; 10(1):22317. PubMed ID: 33339845
[TBL] [Abstract][Full Text] [Related]
12. Urine metabolomics for assessing fertility-sparing treatment efficacy in endometrial cancer: a non-invasive approach using ultra-performance liquid chromatography mass spectrometry.
Chen J; Liu J; Cao D
BMC Womens Health; 2023 Nov; 23(1):583. PubMed ID: 37940929
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of patients with and without prostate cancer using urine
Hasubek AL; Wang X; Zhang E; Kobus M; Chen J; Vandergrift LA; Kurreck A; Ehret F; Dinges S; Hohm A; Tilgner M; Buko A; Habbel P; Nowak J; Mercaldo ND; Gusev A; Feldman AS; Cheng LL
Magn Reson Chem; 2023 Dec; 61(12):740-747. PubMed ID: 37654196
[TBL] [Abstract][Full Text] [Related]
14. Does the 1H-NMR plasma metabolome reflect the host-tumor interactions in human breast cancer?
Richard V; Conotte R; Mayne D; Colet JM
Oncotarget; 2017 Jul; 8(30):49915-49930. PubMed ID: 28611296
[TBL] [Abstract][Full Text] [Related]
15. Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.
Cala MP; Aldana J; Medina J; Sánchez J; Guio J; Wist J; Meesters RJW
PLoS One; 2018; 13(2):e0190958. PubMed ID: 29438405
[TBL] [Abstract][Full Text] [Related]
16. LC-MS/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer.
Gong S; Wang Q; Huang J; Huang R; Chen S; Cheng X; Liu L; Dai X; Zhong Y; Fan C; Liao Z
Methods; 2024 Feb; 222():100-111. PubMed ID: 38228196
[TBL] [Abstract][Full Text] [Related]
17. Urine and serum metabolomic analysis of endometrial cancer diagnosis and classification based on ultra-performance liquid chromatography mass spectrometry.
Chen J; Lu H; Cao D; Sun J; Qi F; Liu X; Liu J; Yang J; Yu M; Zhou H; Cheng N; Wang J; Zhang Y; Peng P; Wang T; Shen K; Sun W
Metabolomics; 2024 Jan; 20(1):18. PubMed ID: 38281200
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registry.
Dougan MM; Li Y; Chu LW; Haile RW; Whittemore AS; Han SS; Moore SC; Sampson JN; Andrulis IL; John EM; Hsing AW
BMC Cancer; 2018 May; 18(1):532. PubMed ID: 29728083
[TBL] [Abstract][Full Text] [Related]
19. Application of NMR metabolomics to search for human disease biomarkers.
Gebregiworgis T; Powers R
Comb Chem High Throughput Screen; 2012 Sep; 15(8):595-610. PubMed ID: 22480238
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic alterations in invasive ductal carcinoma of breast: A comprehensive metabolomic study using tissue and serum samples.
More TH; RoyChoudhury S; Christie J; Taunk K; Mane A; Santra MK; Chaudhury K; Rapole S
Oncotarget; 2018 Jan; 9(2):2678-2696. PubMed ID: 29416801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
